Search Results - "Ellis, Leslie"

Refine Results
  1. 1

    Solving the Nightmare Mystery: The Autonomic Nervous System as Missing Link in the Aetiology and Treatment of Nightmares by Ellis, Leslie A.

    Published in Dreaming (New York, N.Y.) (01-03-2023)
    “…Current theories about the aetiology of nightmares and mechanisms of action that account for their successful treatment have not yet taken the polyvagal theory…”
    Get full text
    Journal Article
  2. 2

    Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia by Klepin, Heidi D., Geiger, Ann M., Tooze, Janet A., Kritchevsky, Stephen B., Williamson, Jeff D., Pardee, Timothy S., Ellis, Leslie R., Powell, Bayard L.

    Published in Blood (23-05-2013)
    “…We investigated the predictive value of geriatric assessment (GA) on overall survival (OS) for older adults with acute myelogenous leukemia (AML). Consecutive…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Common Factors Leading to a Universal Approach to Dreamwork: A Qualitative Analysis by Ellis, Leslie A

    Published in Dreaming (New York, N.Y.) (01-03-2019)
    “…Using 2 texts that survey the most prevalent current Western Euro-based dreamwork modalities, this qualitative analysis identifies common factors in dreamwork…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia by Anderson, Rebecca, Miller, Lance D., Isom, Scott, Chou, Jeff W., Pladna, Kristin M., Schramm, Nathaniel J., Ellis, Leslie R., Howard, Dianna S., Bhave, Rupali R., Manuel, Megan, Dralle, Sarah, Lyerly, Susan, Powell, Bayard L., Pardee, Timothy S.

    Published in Nature communications (30-03-2022)
    “…Devimistat is a TCA cycle inhibitor. A previously completed phase I study of devimistat in combination with cytarabine and mitoxantrone in patients with…”
    Get full text
    Journal Article
  8. 8

    Left Ventricular Mass Change After Anthracycline Chemotherapy by Jordan, Jennifer H, Castellino, Sharon M, Meléndez, Giselle C, Klepin, Heidi D, Ellis, Leslie R, Lamar, Zanetta, Vasu, Sujethra, Kitzman, Dalane W, Ntim, William O, Brubaker, Peter H, Reichek, Nathaniel, D'Agostino, Jr, Ralph B, Hundley, W Gregory

    Published in Circulation. Heart failure (01-07-2018)
    “…Myocardial atrophy and left ventricular (LV) mass reductions are associated with fatigue and exercise intolerance. The relationships between the receipt of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Qualitative Changes in Recurrent PTSD Nightmares After Focusing-Oriented Dreamwork by Ellis, Leslie A

    Published in Dreaming (New York, N.Y.) (01-09-2016)
    “…Although there has been considerable quantitative research to support the use of dreamwork methods that use imagery to treat PTSD-related nightmares, there has…”
    Get full text
    Journal Article
  13. 13

    Aortic Stiffness Increases Upon Receipt of Anthracycline Chemotherapy by CHAOSUWANNAKIT, Narumol, D'AGOSTINO, Ralph, GREGORY HUNDLEY, W, HAMILTON, Craig A, LANE, Kimberly S, NTIM, William O, LAWRENCE, Julia, MELIN, Susan A, ELLIS, Leslie R, TORTI, Frank M, LITTLE, William C

    Published in Journal of clinical oncology (01-01-2010)
    “…PURPOSE Cancer survivors exposed to anthracyclines experience an increased risk of cardiovascular (CV) events. We hypothesized that anthracycline use may…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Frontal Brain Activity and Subjective Arousal During Emotional Picture Viewing in Nightmare Sufferers by Carr, Michelle, Summers, Richard, Bradshaw, Ceri, Newton, Courtney, Ellis, Leslie, Johnston, Erin, Blagrove, Mark

    Published in Frontiers in neuroscience (30-09-2020)
    “…Nightmares are intensely negative dreams that awaken the dreamer. Frequent nightmares are thought to reflect an executive deficit in regulating arousal. Within…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen by Reed, Daniel R., Wooster, Margaux, Isom, Scott, Ellis, Leslie R., Howard, Dianna S., Manuel, Megan, Dralle, Sarah, Lyerly, Susan, Bhave, Rupali, Powell, Bayard L., Pardee, Timothy S.

    Published in Annals of hematology (01-04-2023)
    “…Acute lymphoblastic leukemia (ALL) is an aggressive bone marrow cancer with disparate outcomes. Data on patient outcomes in real world settings outside of…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Efficacy of 10-day decitabine in acute myeloid leukemia by Bouligny, Ian M., Mehta, Vivek, Isom, Scott, Ellis, Leslie R., Bhave, Rupali R., Howard, Dianna S., Lyerly, Susan, Manuel, Megan, Dralle, Sarah, Powell, Bayard L., Pardee, Timothy S.

    Published in Leukemia research (01-04-2021)
    “…•Real world outcomes using the 10 day decitabine regimen in AML are lacking.•10-day decitabine had an ORR of 36.1% in AML in the upfront setting.•10-day…”
    Get full text
    Journal Article